Search

everythinglearnresearchcommunity

for

Search:↓

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

A mild botulinum toxin injection improved sperm production and movement in aging mice.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

A 15-year-old girl with missed periods was diagnosed with a pituitary disorder and treated with hormones and steroids.

Public interest in finasteride's sexual side effects has significantly increased, highlighting the need for better patient discussions.

Balding doesn't reduce the number of hair follicles, it just makes them smaller.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Minoxidil lotion may harm male reproductive health.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Men with severe hair loss may have poorer sperm quality.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Man experienced sexual dysfunction, depression, breast growth, and skin discoloration after taking finasteride for hair loss.

Not eating enough protein can cause hair roots to shrink and lose color, and hair to become thinner.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Routine genetic testing is crucial for early diagnosis and better management of Turner’s syndrome with 21-hydroxylase deficiency.